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Background: Use of e-cigarettes (inhalable vapour producing battery powered devices that aim to simulate
tobacco cigarettes), is rising in a number of countries, but as yet none of these products are regulated as medicinal
devices or available as smoking cessation treatments. Smokers seeking support from health professionals to stop
smoking are interested in e-cigarettes and may be buying them to aid a quit attempt. Determining what smokers
are asking, and what health professionals think about these products may have implications for smoking treatment
services in a number of countries.
Methods: Stop smoking service advisors, managers and commissioners in the United Kingdom were asked to take
part in two surveys on e-cigarettes. Data was analysed from 587 practitioners who completed a survey in 2011 and
705 practitioners who completed a repeat survey in 2013. Responses to multiple choice questions and free text
comments were analysed.
Results: Responding practitioners reported that interest in, and use of, e-cigarettes is growing among adults
seeking help to stop smoking in the UK. In 2013 91% of respondents reported that interest in e-cigarettes had
grown in the past year and whilst in 2011, 2% of respondents reported a ‘quarter to a half’ of their clients saying
that they were regularly using e-cigarettes, by 2013 this had increased to 23.5% (p < .001). Responding practitioners’
views towards e-cigarettes became more positive between the first and second surveys (15% strongly agreed/
agreed in 2011 that ‘e-cigarettes are a good thing’ rising to 26% in 2013). However, they continued to have
concerns about the products. In particular, analysis of free text responses suggested practitioners were unsure
about safety or efficacy for smoking cessation, and were worried that smokers may become dependent on the
products. Practitioners were also aware of the potential of e-cigarettes to undermine smokers’ willingness to use
evidence-based methods to stop, and to challenge policies aiming to denormalise tobacco smoking.
Conclusions: Health professionals are asking for reliable and accurate information on e-cigarettes to convey to
smokers who want to quit. Randomized controlled trials and ongoing surveillance of e-cigarette use and its
consequences for smoking cessation rates and smoking treatment services are required.
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E-cigarettes are battery powered devices that aim to
simulate tobacco cigarettes by heating nicotine and other
chemicals into an inhalable vapour. Use of e-cigarettes
has grown rapidly in recent years although their avail-
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unless otherwise stated.International Tobacco Control Survey conducted in US,
Canada, Australia and UK, suggest that 2.9% of current
and ex-smokers in 2010 were users of e-cigarettes, 7.6%
had tried e-cigarettes and 46.6% were aware of them [1].
In the UK, it is estimated that there were 600,000
current users in 2012 and that use more than doubled
from 2.7% of the population in 2010 to 6.7% in 2012 [2].
Current estimates suggest that in 2014 there are well in
excess of two million users [3]. In line with this increase
in use, a growing body of research on these productsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ficacy for smoking cessation remain limited [4-6].
E-cigarettes usually provide nicotine and potentially act
as a behavioural replacement for smoking [7,8]. Although
they usually deliver less nicotine than cigarettes, they have
been found to alleviate craving and cigarette withdrawal
symptoms [9-11]. Several surveys report that e-cigarette
users consider the product a satisfactory replacement for
cigarettes and an effective stop-smoking treatment [12-15].
It is therefore not surprising that health professionals who
support smokers to stop are being asked to provide infor-
mation on e-cigarettes [16]. However, no country has yet
licensed e-cigarettes as medicines and they are not avail-
able anywhere on prescription [17-19].
In the UK, the Medicines Healthcare Regulatory Agency
(MHRA) announced in June 2013 that e-cigarettes manu-
facturers would be required to seek a medicinal license if
their products contained nicotine and were intended to act
as a cessation aid from 2016 [20]. However, this decision
was to be linked to European legislation (the EU Tobacco
Products Directive) and this legislation now looks likely to
permit many e-cigarettes to continue to be sold as con-
sumer products in Europe although manufacturers will
need to provide better quality information on safety and
quality [21].
In the UK, a small proportion of smokers are willing
to access the UK national Stop Smoking Service (SSS)
for help with their quit attempt (around 5% of those
making a quit attempt with pharmacological or behav-
ioural support) but this still amounts to over 700,000
clients each year [22,23]. Other surveys have looked at
how SSS are responding to the increased use of e-
cigarettes and have found that the use of e-cigarettes by
clients of SSS is common, but that there is little or no
systematic recording of their use [16].
SSS clients and staff are an important group to study
for a number of reasons. First a growing number of coun-
tries around the world are offering smoking cessation ser-
vices [24] and clients and staff in some of these other
countries may have similar questions about e-cigarettes.
Such staff are credible sources of information for smokers
and are trained to accurately describe stop smoking medi-
cations to clients [25], thus any concerns they have over
answering clients’ queries about a new product should be
addressed. Secondly smokers attending the UK services
have a greater chance of quitting than smokers attempting
to stop by using medication or willpower alone [26], and
the reported experience of smokers already willing to use
effective cessation aids regarding e-cigarettes may be par-
ticularly valuable. Finally, the views of service staff on
e-cigarettes can be useful for policy makers in consider-
ing how these products may impact upon the services
and medication currently provided by SSS and whether
e-cigarettes may or may not have a place in tobaccoharm reduction, as staff could be tasked with imple-
menting new policies on e-cigarettes in the future.
This study’s objective was to explore the extent to
which smokers seeking help to stop smoking with the
SSS were asking about e-cigarettes, the reported usage
of e-cigarettes by clients, the concerns clients presented
about e-cigarettes and what the views of practitioners
were regarding these products. Within the study there is
a primary source of information – practitioners’ opin-
ions of e-cigarettes, and also a secondary source of
information – practitioners’ reports of their clients’ ex-
perience of e-cigarettes.
Two cross-sectional surveys were conducted in 2011
and 2013 with smoking cessation practitioners working
in a SSS. This was a period when national and European
policy on e-cigarettes was gradually developing and so an
important interval within which to track any changes over
time. The surveys were designed to assess the following:
 whether queries about and use of e-cigarettes
changed between the two surveys,
 what types of queries were being received in 2011
and 2013,
 the extent to which practitioners perceived
e-cigarettes as a positive or negative development
and whether this changed over time,
 needs for more research and guidance and the
assessment of current guidance.
Methods
Setting and procedures
In 2011 the authors developed a short questionnaire on
e-cigarettes for SSS practitioners, following a discussion
on the topic at a national conference. The questionnaire
was piloted with two practitioners and then developed
into an online survey using Bristol Online Surveys [27].
In June 2011 a link to this survey was sent by the National
Centre for Smoking Cessation and Training (NCSCT), the
main body for cessation training in England, to all SSS
practitioners registered with them. These practitioners
were staff engaged in supporting smokers to stop or
managing staff who supported smokers to stop (generally
employed by specialist stop smoking services, GP prac-
tices and pharmacies). Responses were received between
June and August 2011, with one reminder issued in July.
In June 2013, the survey was reviewed and slightly revised
by the study team with a view to assessing any changes in
opinions amongst practitioners in the intervening period.
A link to this second survey was sent to practitioners on
the same list and responses were received in July 2013,
with no reminders required as the volume of responses re-
ceived was large. The surveys took less than five minutes
to complete. As it was voluntary, reviewed current service
provision and the contact list was held by a national
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was possible for practitioners to complete both surveys.
Measures
Four topics were covered by the two surveys: first, the
extent of clients’ queries about e-cigarettes and practi-
tioners’ estimates of prevalence of use among their cli-
ents (ever use and regular use) (see Table 1 for response
options); secondly the types of queries that practitioners
received from clients. Respondents were asked what
types of questions they had received about e-cigarettes
and were provided with a list of twelve potential client
queries: where to get them, how much they cost, whether
they were legal, whether SSS provide them and why SSS
don’t provide them, whether they contained harmful addi-
tives, how safe they are for users or others around them,
whether they were effective for stopping smoking or cut-
ting down or avoiding smoking, how they function and
any other problems with the product. In 2011 respondents
were able to choose one of these queries and in 2013 re-
spondents could choose as many queries as they liked.
Thirdly the practitioners’ own views on e-cigarettes were
elicited through asking, using a five point Likert scale (see
Table 1 for response options), to indicate the extent they
agreed that “E-cigarettes are a good thing”. In addition
respondents were able to leave free-text comments on
e-cigarettes or their use by clients which provided a
more nuanced response. Fourthly practitioners’ needs
for further guidance on e-cigarettes and their assessment
of current available guidance in the UK on e-cigarettes
were assessed. In the 2011 survey practitioners were
asked if they wanted more information and guidance on
e-cigarettes using a Likert scale (see Table 2 for response
options). In 2013 practitioners were asked whether they
knew about the recent MHRA guidance that had been
published just before the second survey and whether
they thought it was useful using a variety of response
scales (see Table 2 for response options). These ques-
tions were derived specifically for this study.
Analysis
Stata [28] was used to explore prevalence of use and quer-
ies and attitudes towards e-cigarettes. Chi square tests
were used to compare differences between the 2011 and
2013 surveys. Responses to questions about information
and guidance were dichotomised into ‘yes’ or ‘no’, ‘true’ or
‘false’ or ‘strongly agree’ and ‘agree’ compared with ‘neu-
tral’, ‘disagree’ and ‘strongly disagree’. Percentages for the
dichotomies were calculated and tabulated.
For the analysis of query type, counts refer to the
number of queries rather than the number of respon-
dents: in 2011 each respondent could choose one of 12
query types and 506 respondents indicated a query type
so there were 506 queries. In 2013 respondents couldchoose as many of the 12 query types as they liked. A
total of 3692 queries were indicated (on average 5 of the
12 query types were indicated by each practitioner). We
could not directly compare between years because in
2011 respondents only indicated one query type whereas
in 2013 respondents could indicate as many as required.
Comments were transposed verbatim and analysed sep-
arately. A coding frame was devised for the 2011 survey.
As this is a new area codes were generated from the data.
Initially each comment was categorised as belonging to
one or more of three macro codes ‘positive stance on
e-cigarettes’, ‘negative stance on e-cigarettes’ and ‘informa-
tion/guidance requirements’. The data in each of these
macro codes were then divided into topics and, when re-
quired, subtopics. When the 2013 verbatim data became
available comments were coded into the existing codes
when possible and new codes and subcodes were added
where necessary. The coding frame was initially developed
by one author and then revised and developed by another
author with input from a third author. The number of
comments in each code were summed and converted to a
proportion of the total comments from each survey (see
Additional file 1).Results
In 2011, 587 out of 3075 practitioners registered with the
NCSCT responded and in 2013 705 out of 20 024 regis-
tered practitioners responded. Note that the survey period
was shorter in 2013 as the desired sample size was
achieved more quickly. In 2011 85% were advisors, 8%
were managers and 4% were commissioners and 4% were
‘other’ and in 2013 78% were advisors, 8% were managers
and 2% were commissioners. In 2011, 174 practitioners
entered comments and 263 did so in the 2013 survey.Prevalence of interest in and use of e-cigarettes among
SSS clients
There was a significant increase in reported enquiries
from clients. In 2011 about two thirds (64%) of respon-
dents said more clients were asking about e-cigarettes,
by 2013 this had risen to 91% (p < .001, Table 1). The
proportion of clients reported by respondents as ever
having used an e-cigarette was also higher in the 2013
survey (p < .001): in 2011 the majority (80%) said less
than a quarter of their clients had reported ever using
an e-cigarette, by 2013 this had dropped to 43% but the
percentage reporting that a quarter to a half of clients
had ever used e-cigarettes rose from 8% in 2011 to 40%
in 2013. Reports of regular use of e-cigarettes also
significantly increased: in 2011, 2% of respondents re-
ported a ‘quarter to a half ’ of their clients saying that
they were regularly using e-cigarettes, by 2013 this had
increased to 24% (p < .001).
Table 1 Queries about, use of and opinions on e-cigarettes among clients as reported by SSS practitioners
2011 survey 2013 survey
N % N % p
Clients asking about e-cigscompared to
one year ago
P < .001
More clients asking 338 64.3 607 90.7
Same proportion 129 24.5 48 7.2
Fewer clients asking 59 11.2 14 2.1
Total 526 100.0 669 100.0
% clients ever used e-cigs P < .001
None 50 9.9 13 2.0
Less than a quarter 404 79.8 283 43.2
Quarter to a half 38 7.5 262 40.0
Half to three quarters 6 1.2 80 12.2
More than three quarters 8 1.6 17 2.6
Total 506 100.0 655 100.0
% clients regularly using e-cigs P < .001
None 90 18.6 25 3.8
Less than a quarter 382 79.1 445 67.8
Quarter to a half 11 2.3 154 23.5
Half to three quarters 0 0.0 23 3.5
More than three quarters 0 0.0 9 1.4
Total1 483 100.0 656 100.0
Clients queries about e-cigs P < .001 P < .001
Where to get them? 249 49.2 227 6.1
Do SSS provide them? 4 0.8 569 15.4
Why don’t SSS provide? 36 7.1 434 11.8
How much do they cost? 3 0.6 188 5.1
Are they legal? 0 0.0 138 3.7
Contain harmful additives? 63 12.5 356 9.6
Safe for users? 67 13.2 436 11.8
Safe for OTHERS around? 2 0.4 122 3.3
Effective for stopping? 68 13.4 514 13.9
Effective for cutting down? 2 0.4 341 9.2
Problems with products? 1 0.2 100 2.7
How they work? 11 2.2 267 7.2
Total queries1 506 100.0 3692 100.0
‘E-cigs are a good thing’ P < .001
strongly agree 27 4.6 47 6.7
agree 60 10.2 135 19.2
unsure 282 48.0 293 41.6
disagree 123 21.0 94 13.3
strongly disagree 95 16.2 106 15.0
Total 587 100.0 675 100.0
1Totals for clients’ queries analysis refer to number of queries.
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Table 2 Summary of comments from SSS practitioners in 2011 (n = 174 comments) and 2013 (n = 263 comments)
% 2011 survey
comments
% 2013 survey
comments
Change
Positive comments 38 40 +2
Popular 8 10 +2 “it is very popular. It’s no good ignoring it…it’s here to stay”
Help with quitting 9 12 +3 “the majority found them successful in helping them to quit”
Reduce harm 9 13 +3 “A good, harmless e.cig has to be better than smoking”
Very like cigs- cf NRT 12 6 −6 “All of my clients found e cigarettes a lot better than using
inhalators. They felt it was more like smoking”
Negative comments 49 69 +20
Do not help quitting 20 12 −8 “Anything that still looks and feels like a cigarette is not
adequately breaking of the old habits”
Operational issues 10 6 −4 “Several clients have relapsed when they ran out of refills for
device or could not wait for it to charge”
Safety (inc dependence) 11 24 +13 “like giving Heroin addicts Methadone” “they seem to be as
addictive (if not more) than cigarettes”
Undermines other tobacco
control measures
9 27 +19 Prevention: “Children and young people see the device as
fun”
Marketing bans: “they are put in packs like cigarettes and
allowed to place advertisements”
Pharmacotherapy: “A client..quit for 6 weeks using the
inhalator …He purchased an e-cig… and found that he
could get the “hit” that cigarettes used to give him. This lead
to increased strong cravings and he eventually returned to
smoking. If he had continued with the slow, gentle levels of
nicotine from the inhalator I feel he would have been more
likely to stay quit”
SSS: “They are reducing the numbers… accessing the
evidence based smoking cessation services”
Smokefree: “I feel it undermines the denormalisation of
smoking and confuses the SF policies I write”
Research/guidance needs 51 55 +4
Need more info/guidelines 28 24 −5 “My organisation refuses to rule or take a stance on them so
advisors are left in a limbo”
Companies involved 21 14 −7 “I feel young people will become addicted to nicotine by
using them and big tobacco is quids in!!”
Probs with current guidelines 1 9 +9 “How can the MHRA state that no e-cigs tested by them
would be licensed yet make no move to restrict their sale for
3 years?”
Integration with SSS 1 8 +7 Pro: “I feel that any ‘safer’ alternative to smoking should be
available to clients through NHS services”
Anti:
“We are a Stop Smoking Service, and we have to remember
that is the aim, to help people stop smoking”
“The ability to deliver the harm reduction [NICE] guidance on
tight tobacco control budgets is… a concern”
Note that comments could include positive, negative and research/guidance needs statements so percentages do not sum to 100.
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In 2011 nearly half of queries mentioned concerned
‘where to get them’ (49%). The most common questions
in 2013 (representing more than 10% of answers) were ‘do
SSS provide them’ (15%), ‘why don’t SSS provide them’
(12%), ‘are they safe for users’ (12%) and ‘are they effective
for stopping smoking’ (14%).Positive and negative views of e-cigarettes among
practitioners
Practitioner opinion on whether e-cigarettes were ‘a good
thing’ shifted significantly within the two years (p < .001).
Despite around half still saying they were unsure about
these products (48% in 2011 and 42% in 2013), there was
more support for the view that e-cigarettes were a good
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26% in 2013, coupled with a 9% drop in those who dis-
agreed (from 21% to 13%) between 2011 and 2013.
Many of the comments also addressed whether respond-
ing practitioners had a positive or negative opinion of e-
cigarettes (Table 2). Analysis of positive comments (such as
their popularity, success in helping with smoking cessation
and harm reduction) indicated little change between 2011
and 2013. A 2011 comment stated “they are very good aid
to quit smoking” and a 2013 comment stated “I think that
e-cig are very good news”. However, a larger proportion of
the comments in the later survey indicated that respondents
had growing concerns about the safety of e-cigarettes, par-
ticularly about clients becoming dependent on the products
(11% in 2011 compared with 24% in 2013). For example one
of the seven 2011 comments mentioning dependence was:
“I recently saw a patient who had become addicted to
the ‘e-cigarette’. He was using approximately 55 mg of
Nicotine per day and was unable to leave the house
without a supply… I sincerely hope that this is not the
tip of the iceberg”.
In 2013 one of the 41 comments that mentioned de-
pendence was:
“over the last few month[s] more clients are coming
to the stop smoking clinics saying they have tried
e-cigarettes but they still wanted to smoke as soon as
they didn[‘] t use them”.
Thus dependence appeared, to respondents, to be an
emerging issue with e-cigarettes.
Another concern was the possibility that e-cigarettes
might undermine other tobacco control measures (9%
in 2011 compared with 27% in 2013). For example,
respondents expressed concern that fewer smokers were
using stop smoking services or other evidence-based smok-
ing treatment options in favour of using e-cigarettes. One
practitioner suggested: “A lot of people are now avoiding
accessing services as we do not supply e cigarettes.” Some
were worried that e-cigarette advertising could contribute
to ‘re-normalising’ smoking or undermine the enforcement
of smokefree legislation for example one practitioner com-
mented “[Local] schools… have had disruptions in exam
and classroom enviro[n]ments as young people are.. show-
ing tutors the packets where it states ‘safe to use’”. Guide-
lines are needed to enable the SSS to provide advice to
such institutions used by young people.
Respondents’ views of available guidance and
information on e-cigarettes
Over 90% of respondents agreed that more research and
information were needed in 2011 (Table 3). In 2013,nearly 90% had heard about the decision in the UK by
the MHRA to pursue regulation of e-cigarettes as medi-
cines from 2016 and 80% agreed (or strongly agreed)
that this was a positive step. The majority were also aware
of the limitations of the MHRA’s decision with less than a
fifth believing that the decision enabled all e-cigarettes to
be licensed and only 16% agreeing that new novel devices
will be denied to smokers. There was also confusion about
the implications of the MHRAs move for e-cigarette mar-
keting with the respondents equally divided over whether
or not marketing to children would be prohibited. Only
7% agreed with tobacco companies selling e-cigarettes im-
plying that most responding practitioners would welcome
further regulation in this direction.
Despite the MHRA announcement and accompanying
published research from a range of countries on e-
cigarette products in 2013, there were a similar propor-
tion of open-ended comments in both surveys requesting
more research and clearer information for health profes-
sionals in terms of what they could say to their clients
about these products (51% in 2011 and 55% in 2013)
(Table 2). One advisor in 2013 voiced these concerns:
“[we appear] impotent to the issue…: unable to recom-
mend the products or not” In the 2013 survey there
were also questions about how best to support smokers
who were trying to stop while using e-cigarettes along-
side licensed medicines such as Nicotine Replacement
Therapy (NRT) and concerns about the delay in licensing
any e-cigarettes (for example: “a safe licensed e-cigarette
that stop smoking services can recommend/prescribe is
definitely needed in the near future”) so that they could be
prescribed to smokers trying to quit.
Discussion
To our knowledge this is the first published paper to re-
port on repeat surveys of smoking cessation practitioners
and their clients’ reported use of, and concerns about, e-
cigarettes. The findings highlight significant change in the
extent to which adults seeking help to stop smoking in the
UK are asking about e-cigarettes: 91% of responding prac-
titioners in 2013 had experienced an increase in queries
from smokers. The proportion of respondents who had no
clients regularly using e-cigs fell from 19% to 4%. This re-
flects the increasing number of people using e-cigarettes
in the UK in this period, which has also been reported
elsewhere [2].
Questions were also included about e-cigarettes in the
NCSCT SSS Practitioner Survey carried out between 4th
December 2012 and 4th January 2013 (N = 1284) [16].
Identical questions were used to assess ever use and regu-
lar use. The modal category for ever use was ‘less than a
quarter’ encompassing 52% of responses. In the 2011 sur-
vey reported here, this category included 80% of responses
and in July 2013 this category included 43% of responses.
Table 3 Practitioners opinions of available guidance on e-cigarettes
%
2011
Need more information (strongly agree/agree* vs neutral, disagree, strongly disagree) 90.2
Need more research (strongly agree/agree vs neutral, disagree, strongly disagree) 91.0
2013
Do you know about the MHRA announcement about regulating e-cigarettes? (yes vs no)** 86.6
The MHRA decision to regulate e-cigarettes is a positive step for public health (strongly agree/agree vs neutral, disagree, strongly disagree) 81.3
The MHRA decision means that all e-cigarettes are now licensed by the MHRA (true vs false)** 18.7
The MHRA decision to regulate e-cigarettes will deny smokers access to new novel nicotine devices (strongly agree/agree vs neutral,
disagree, strongly disagree)
16.3
MHRA regulation of e-cigarettes will prohibit marketing to children (true vs false)** 51.4
How do you feel about companies that are subsidiaries of tobacco companies bringing medications to market? (strongly agree/agree vs
neutral, disagree, strongly disagree)
6.7
*Percentages of practitioners whose answer was in the italicised categories are tabulated.
**Only includes responses from English practitioners (n = 619) where MHRA guidance applies directly.
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Survey reported that ‘a quarter to half of clients’ were
regularly using e-cigarettes. In the 2011 and July 2013 sur-
veys reported here the percentages were 2% and 23.5% re-
spectively. Thus the NCSCT Practitioner Survey results
were intermediate to the results of the two surveys re-
ported here but slightly closer to the July 2013 survey,
as expected. Results are expected to be close as the sam-
pling frames were similar for both studies. However
21% of NCSCT Practitioner Survey respondents reported
that they had no clients who regularly used e-cigarettes
which is higher than both surveys reported here. This
may reflect that the surveys reported here were only fo-
cused on e-cigarettes and so may have attracted more
responses from practitioners whose clients were using
e-cigarettes.
Currently most smoking cessation practitioners do not
recommend e-cigarettes as cessation aids, because they
are not licensed as medicines and therefore health service
staff are not able to provide them [16]. Practitioners, how-
ever, do report clients using e-cigarettes for quitting and
harm reduction [16]. In this current study the proportion
holding positive views was higher in the second survey,
perhaps reflecting the growing acceptance or visibility of
e-cigarettes in UK society. Over a tenth of respondents
who commented made supportive statements suggesting
that they believed that e-cigarettes helped clients with ces-
sation or harm reduction in terms of cutting down their
smoking. In another study it was found that, despite only
recruiting smokers who wanted to use e-cigarettes for
harm reduction not cessation, 9% had quit by 52 weeks
[29]; so there is some evidence that harm reduction with
e-cigarettes may lead to abstinence from smoking. Re-
spondents recommended that, in their view, further
research and guidance are needed in order to enable
practitioners to advise smokers about any risks, andabout e-cigarettes’ potential role as an alternative to smok-
ing. There was considerable uncertainty about existing
current guidance in the UK and its implications.
Most responding practitioners were not positive about
e-cigarettes in either survey; in particular they were per-
ceived as promoting the continuation of smoking and
challenging smoke free legislation. Marketing and adver-
tising of combustible cigarettes has largely been banned
and respondents raised concerns about the marketing of
a product that resembled combustible cigarettes, although
this was perhaps a reflection more of issues raised by the
wider tobacco control community [30,31] rather than
responding practitioners’ experiences with clients. There
were, however, particular concerns raised in the com-
ments about responding practitioners’ observations of the
impact of e-cigarettes on young people. Some studies sug-
gest that there is the potential for children to confuse e-
cigarettes with combustible cigarettes [32], that e-cigarette
use is growing fast [33] and that e-cigarette use is appar-
ent among some young people who do not smoke com-
bustible cigarettes [34]. Whether using e-cigarettes can
become a gateway to using combustible cigarettes has not
been established. More research on this is urgently
required and the new UK legislation banning sales of
e-cigarettes to children under the 18, announced in
January 2014 [35] is likely to be welcomed.
There were also growing numbers of reports of SSS
clients who had become dependent on e-cigarettes.
Elsewhere [36] it has been found that 89% of e-cigarette
users continued to use e-cigarettes one year after they
were first monitored. A recently published study has
found that it is possible for e-cigarette users to get as
much nicotine from e-cigarettes as from combustible
cigarettes [37] which heightens the likelihood of depend-
ence occurring. However this also heightens the chances
of e-cigarettes being effective for cessation. Furthermore
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substance [38] although varying levels of nicotine in un-
regulated e-cigarettes may have consequences [8] and the
effects of inhaling e-cigarette vapour in indoor air, particu-
larly over a sustained period, are not yet fully understood
[39,40].
Responding practitioners had concerns that potential
quitters were bypassing licensed cessation quitting aids
in favour of e-cigarettes. Nevertheless the survey suggest
that smokers using e-cigarettes still approached the SSS
suggesting such clients believed they required more than
just e-cigarettes to achieve success in their quit attempt.
In 2012/13 the number of clients accessing the SSS fell
slightly for the first time in a number of years, but the
proportion who successfully quit rose [23]. It is not pos-
sible to ascertain whether e-cigarettes were responsible
for either of these changes. International data is also un-
clear on whether e-cigarettes do provide a clear cessa-
tion advantage, although research in this area is growing
rapidly [6,41,42].
Limitations
Our conclusions are limited by the small sample size
and the need to rely on practitioners’ recall of clients’
stated experiences which adds layers of removal from
actual events. It was not possible to know how much
practitioners’ opinions were shaped by what they had
heard through the media or tobacco control networks or
whether what they reported was limited to their direct
experience of working with clients. Furthermore, clients’
descriptions of their usage of e-cigarettes may have vari-
ations in accuracy. There are also statistical limitations:
the chi square tests were conducted as if the two sam-
ples were independent - however it is likely that some
respondents completed both surveys.
New questions were developed for these surveys and
some issues arose with a couple of these. In 2011 clients
were only able to indicate one query type they had received
from clients whereas in 2013 they could indicate as many
as applied. This meant that we could not statistically com-
pare the queries from two surveys. The question “Are e-
cigarettes a ‘good thing?’” has ambiguities as practitioners
could be comparing e-cigarettes to combustible cigarettes
or to not smoking at all. The complexities of this issue be-
come apparent when inspecting the verbatim comments.
It is not possible to calculate the response rate be-
cause the total number of practitioners in the UK is un-
known [16]. However commissioners in England now
tend to make registration with NCSCT mandatory so it
is likely that the NCSCT by 2013 had registered all
English practitioners.
Given the higher reported client use of e-cigarettes by
practitioners in the sample compared with practitioners
generally [16], it is likely that the results are affected bysome response bias. Thus readers should be wary of gen-
eralising the results reported here to all practitioners.
In addition, this dataset was not sufficient to be able
to understand the implications of the MHRA decision in
the UK - to do so it would be necessary to have time series
data and to take into account other changes in marketing
and smoking prevalence. Findings from the UK may not
necessarily be applicable to other countries particularly
where e-cigarette sales are more restricted.
Conclusions
The surveys suggest that there is substantial interest in
using e-cigarettes to support quit attempts among smokers
seeking help from smoking cessation services and that this
interest is growing. The results also indicate that these
smokers are asking cessation practitioners a range of im-
portant questions about these products. The quantitative
data and comments at both time points however, showed
lack of consensus among practitioners on whether e-
cigarettes are a positive or negative development and thus
views of whether e-cigarettes have an important place in
tobacco control and their impact on cessation services
were inconsistent. Despite the MHRA announcement,
practitioners in 2013 continued to ask for more research
and information so that effective guidance for smoking
treatment service clients and their staff can be put in place.
Randomized controlled trials and ongoing surveillance of
e-cigarette use and its consequences for smoking cessation
rates and smoking treatment services are required.
Additional file
Additional file 1: Coding frame for verbatim data. This Microsoft
Excel file contains codes and subcodes and number of times each code
arose in the first and second survey verbatim comments and what
percentage of comments from each survey contained each code.
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